blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2204181

EP2204181 - Protease inhibitors [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  26.06.2015
Database last updated on 07.10.2024
Most recent event   Tooltip26.06.2015Application deemed to be withdrawnpublished on 29.07.2015  [2015/31]
Applicant(s)For all designated states
TRUSTEES OF TUFTS COLLEGE
Ballou Hall
Medford, MA 02155 / US
[2010/27]
Inventor(s)01 / Bachovchin, William W.
75 Cambridge Parkway, Apartment E609
Cambridge, MA 02142 / US
 [2010/32]
Former [2010/27]01 / Bachovchin, William W.
7 Warwick Street
Melrose, MA 02176 / US
Representative(s)Chapman, Paul Gilmour, et al
Marks & Clerk LLP
Atholl Exchange
6 Canning Street
Edinburgh EH3 8EG / GB
[2013/42]
Former [2010/27]Chapman, Paul Gilmour, et al
Marks & Clerk LLP Aurora 120 Bothwell Street
GB-Glasgow G2 7JS / GB
Application number, filing date09012951.130.04.2003
[2010/27]
Priority number, dateUS20020376636P30.04.2002         Original published format: US 376636 P
[2010/27]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2204181
Date:07.07.2010
Language:EN
[2010/27]
Type: A3 Search report 
No.:EP2204181
Date:22.09.2010
[2010/38]
Search report(s)(Supplementary) European search report - dispatched on:EP23.08.2010
ClassificationIPC:A61K38/00, C07K5/08, C07K5/10
[2010/27]
CPC:
C07K7/06 (EP,US); A61K47/64 (EP,US); A61P1/00 (EP);
A61P1/04 (EP); A61P1/10 (EP); A61P13/12 (EP);
A61P15/06 (EP); A61P17/00 (EP); A61P17/06 (EP);
A61P17/14 (EP); A61P19/02 (EP); A61P25/00 (EP);
A61P25/06 (EP); A61P25/08 (EP); A61P25/18 (EP);
A61P25/20 (EP); A61P25/22 (EP); A61P25/24 (EP);
A61P29/00 (EP); A61P3/00 (EP); A61P3/04 (EP);
A61P3/06 (EP); A61P3/10 (EP); A61P31/12 (EP);
A61P31/18 (EP); A61P35/00 (EP); A61P37/02 (EP);
A61P37/06 (EP); A61P37/08 (EP); A61P43/00 (EP);
A61P5/06 (EP); A61P7/00 (EP); A61P9/04 (EP);
A61P9/10 (EP); A61P9/12 (EP); C07F5/025 (EP,US);
C07K5/06052 (US); C07K5/06078 (EP,US); C07K5/06191 (EP,US);
C07K5/0817 (EP,US); C07K5/0827 (EP,US); C07K5/1008 (EP,US);
C07K5/101 (US); C07K5/1013 (EP,US); C07K5/1016 (EP,US);
C07K5/1027 (EP,US); A61K38/00 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2010/27]
TitleGerman:Protease-Hemmer[2010/27]
English:Protease inhibitors[2010/27]
French:Inhibiteurs de protéase[2010/27]
Examination procedure12.11.2009Examination requested  [2010/27]
07.07.2011Amendment by applicant (claims and/or description)
23.08.2011Despatch of a communication from the examining division (Time limit: M04)
23.12.2011Reply to a communication from the examining division
25.09.2014Communication of intention to grant the patent
06.02.2015Application deemed to be withdrawn, date of legal effect  [2015/31]
16.03.2015Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2015/31]
Parent application(s)   TooltipEP03726564.2  / EP1499336
Divisional application(s)EP10011375.2  / EP2319523
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20030726564) is  27.01.2006
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
08.07.2011Request for further processing filed
08.07.2011Full payment received (date of receipt of payment)
Request granted
26.07.2011Decision despatched
Fees paidRenewal fee
12.11.2009Renewal fee patent year 03
12.11.2009Renewal fee patent year 04
12.11.2009Renewal fee patent year 05
12.11.2009Renewal fee patent year 06
12.11.2009Renewal fee patent year 07
25.03.2010Renewal fee patent year 08
12.04.2011Renewal fee patent year 09
28.03.2012Renewal fee patent year 10
12.04.2013Renewal fee patent year 11
25.03.2014Renewal fee patent year 12
Penalty fee
Additional fee for renewal fee
30.04.201513   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]US5776902  (BACHOVCHIN WILLIAM W [US]) [X] 1-15 * the whole document *;
 [X]WO8903223  (BACHOVCHIN WILLIAM W [US], et al) [X] 1-15 * the whole document *;
 [X]EP0195212  (MERRELL DOW PHARMA [US]) [X] 1-15 * the whole document *;
 [X]US4499082  (SHENVI ASHOKKUMAR B [US], et al) [X] 1-15 * the whole document *
 [X]  - BIOCHEMISTRY., US AMERICAN CHEMICAL SOCIETY. EASTON, PA., (19931130), vol. 32, no. 47, pages 12651 - 12655, XP000609102 [X] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1021/bi00210a013
 [X]  - JOURNAL OF BIOLOGICAL CHEMISTRY, US AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD., (19900305), vol. 265, no. 7, pages 3738 - 3743, XP000103667 [X] 1-15 * the whole document *
 [X]  - JOURNAL OF THE AMERICAN CHEMICAL SOCIETY., US AMERICAN CHEMICAL SOCIETY, WASHINGTON, DC., (19980318), vol. 120, no. 10, pages 2211 - 2217, XP002323535 [X] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1021/ja9720220
by applicantWO9734927
 US5834428
 WO9408051
 US5359115
 US5362899
 US5288514
 US5736412
 US5712171
 WO9210092
 WO9309668
 WO9107087
 WO9320242
    - CUYPERS ET AL., J. BIOL. CHEM., (1982), vol. 257, page 7086
    - SCHECHTER; BERGER, BIOCHEM. BIOPHYS. RES. COMMUN., (1967), vol. 27, pages 157 - 162
    - GOLDBERG ET AL., CHEM. & BIOL., (1995), vol. 2, pages 503 - 508
    - COUX ET AL., ANNU. REV. BIOCHEM., (1996), vol. 65, pages 801 - 847
    - DESHAIES, TRENDS CELL BIOL., (1995), vol. 5, pages 428 - 434
    - GANTT ET AL., ANTIMICROB AGENTS CHEMOTHER., (1998), vol. 42, pages 2731 - 2738
    - RETTIG ET AL., PROC. NATL. ACAD. SCI. USA, (1988), vol. 85, pages 3110 - 3114
    - RETTIG ET AL., CANCER RES., (1993), vol. 53, pages 3327 - 3335
    - SCANLAN ET AL., PROC. NATL. ACAD. SCI. USA, (1994), vol. 91, pages 5657 - 5661
    - WELT ET AL., J CLIN. ONCOL., (1994), vol. 12, no. 6, pages 1193 - 1203
    - DRUCKER ET AL., PNAS, (1996), vol. 93, page 7911
    - KUBIAK ET AL., PEPTIDE RES, (1994), vol. 7, page 153
    - The Peptides, ACADEMIC PRESS, (1981), vol. 3, pages 3 - 88
    - Burger's Medicinal Chemistry and Drug Discovery, vol. 1
    - WILDING ET AL., J ENDOCRINOLOGY, (1992), vol. 132, pages 299 - 302
    - STANLEY ET AL., PHYSIOLOGY AND BEHAVIOR, (1989), vol. 46, pages 173 - 177
    - BLONDELLE ET AL., TRENDS ANAL. CHEM., (1995), vol. 14, page 83
    - CHEN ET AL., JACS, (1994), vol. 116, page 2661
    - KERR ET AL., JACS, (1993), vol. 115, page 252
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.